Search results
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoThat specific side effect prompted the CDC last year to recommend that older adults talk to their...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 7 days agoThe FDA has approved Moderna's RSV vaccine for older adults. The Food and Drug Administration on...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 7 days agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...
Why do I keep getting colds every few weeks? 4 reasons why
TODAY via Yahoo News· 2 days agoDuring the height of the pandemic, people were staying home, wearing masks and social distancing....
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 4 days agoIts investors just got some bullish news last week -- news that could unlock a $10 billion market for the company. Let's check out...one product, and...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 3 days agoLast August, it became the first to earn approval for protecting newborn infants as a maternal...
Analysis | Four questions for today’s Fauci hearing
Washington Post· 4 days agoThe Texas Supreme Court rejected a lawsuit that sought to clarify exceptions to the state’s abortion laws. The longtime infectious-disease expert is back...
What’s the state of New Yorkers’ mental health?
Politico· 4 days ago(STAT) — Being a patient...risks, Zack Colman reports. — FDA approves Moderna’s RSV vaccine for older adults, Lauren Gardner reports. MISSED ...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 4 days agoAbrysvo, another RSV vaccine from Pfizer, also earned approval last May for those 60 or older....
Glaxo (GSK) Up 1.6% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 7 days agoSales are expected to be weighted to the second half in preparation for the 2024/25 RSV season....
